Neurobo Pharmaceuticals Inc (NRBO) is down Wednesday morning, with the stock losing -13.60% in pre-market trading to 3.43. NRBO's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, Neurobo Pharmaceuticals Inc ranks higher than 29% of stocks. Neurobo Pharmaceuticals Inc has risen 21.41% over the past month, closing at $3.21 on June 23. During this period of time, the stock fell as low as $2.73 and as high as $3.46. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $16.00.
NRBO has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on NRBO!